Contact
searchSearch
HMP Global

Volume 20 - Issue 3 - March, 2008

Case Report
Transcatheter Closure of Postinfarction Ventricular Septal Rupture
with the Amplatzer® Occluder
08/01/2008
Raúl Moreno-Gómez, MD, PhD; Ana Viana-Tejedor, MD; Mar Moreno, MD
Mechanical complications comprise the second leading cause of in-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI), especially in the elderly.1 Among them, ventricular septal rupture (VSR) complicates...
Mechanical complications comprise the second leading cause of in-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI), especially in the elderly.1 Among them, ventricular septal rupture (VSR) complicates...
Mechanical complications...
08/01/2008
Journal of Invasive Cardiology
Commentary
Drug-Eluting versus Bare-Metal Stents: When and for Whom?
08/01/2008
Rafael Beyar, MD, DSc, MPH; Eugenia Nikolsky, MD, PhD
Percutaneous coronary intervention (PCI) is the most commonly performed treatment modality for obstructive coronary artery disease. Stents are an indispensable component of PCI, allowing substantial improvement in acute and long-term results...
Percutaneous coronary intervention (PCI) is the most commonly performed treatment modality for obstructive coronary artery disease. Stents are an indispensable component of PCI, allowing substantial improvement in acute and long-term results...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Case Report
Brachial Artery Perforation Repaired with Percutaneous
Transfemoral Covered Stent Deployment in a Patient on Abciximab
08/01/2008
Dominic Kelly, BSc, MBChB; Terry Levy, MBBS, BSc, MBChB; Suneel Talwar, MD
Percutaneous coronary intervention is the accepted optimum strategy in the treatment of both myocardial infarction and stable angina resistant to medical therapy.1 Traditionally most procedures have been performed via the femoral access route...
Percutaneous coronary intervention is the accepted optimum strategy in the treatment of both myocardial infarction and stable angina resistant to medical therapy.1 Traditionally most procedures have been performed via the femoral access route...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Clinical Outcomes after Multilesion Percutaneous Coronary
Intervention: Comparison between Exclusive and Selective
Use of Drug
08/01/2008
Robert De Larochellière, MD; Olivier F. Bertrand, MD, PhD; Benjamin Faurie, MD, PhD; Bernard Noel, MD; Josep Rodés-Cabau, MD, PhD; Guy Proulx, MD; Eric Larose, MD, DVM; Can Manh Nguyen, MD; Onil Gleeton, MD; Jean-Pierre Dery, MD, MSc; Louis Roy, MD; Olivier Costerousse, PhD
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have...
08/01/2008
Journal of Invasive Cardiology
Case Report
Acute Pulmonary Edema Due to Pacemaker-Induced Mitral
Regurgitation
08/01/2008
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Subhash Banerjee, MD, FSCAI; Aman Haider, MD
Case Report. An 82-year-old male with ischemic cardiomyopathy underwent permanent pacemaker implantation because of symptomatic intermittent second-degree Mobitz II heart block. Immediately after implantation and while the patient was still...
Case Report. An 82-year-old male with ischemic cardiomyopathy underwent permanent pacemaker implantation because of symptomatic intermittent second-degree Mobitz II heart block. Immediately after implantation and while the patient was still...
Case Report. An 82-year-old male...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Real-World Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors
during Percutaneous Coronary Intervention
08/01/2008
Jeffrey L. Anderson, MD; Joseph Brent Muhlestein, MD, FAHA, FACC; Peter J. Casterella, MD; James R. Revenaugh, MD; James L. Burke, MD; Robert R. Pearson, BS; Tami L. Bair, BS; Heidi T. May, MSPH, PhD; Benjamin Horne, PhD, MPH
Percutaneous coronary intervention (PCI) is commonly employed in the management of patients with coronary artery disease (CAD), but the optimal adjunctive pharmacologic strategy for patients undergoing PCI is a frequently debated issue,...
Percutaneous coronary intervention (PCI) is commonly employed in the management of patients with coronary artery disease (CAD), but the optimal adjunctive pharmacologic strategy for patients undergoing PCI is a frequently debated issue,...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
The Beginning of Balloon Conception and Application in
Peripheral Arterial Disease
08/01/2008
Alfred Bollinger, MD; Maria Schlumpf, PA
When German-born Andreas Roland Grüntzig arrived in 1969 in Zurich, Switzerland, and joined the Angiology Division of the University Hospital, founded some years before, he stated: “I have dedicated my life to the vascular diseases”.1 First,...
When German-born Andreas Roland Grüntzig arrived in 1969 in Zurich, Switzerland, and joined the Angiology Division of the University Hospital, founded some years before, he stated: “I have dedicated my life to the vascular diseases”.1 First,...
When German-born Andreas Roland...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Clinical Outcomes after Multilesion Percutaneous Coronary
Intervention: Comparison between Exclusive and Selective
Use of Drug
08/01/2008
Can Manh Nguyen, MD; Bernard Noel, MD; Guy Proulx, MD; Olivier F. Bertrand, MD, PhD; Eric Larose, MD, DVM; Onil Gleeton, MD; Jean-Pierre Dery, MD, MSc; Benjamin Faurie, MD, PhD; Louis Roy, MD; Olivier Costerousse, PhD; Robert De Larochellière, MD; Josep Rodés-Cabau, MD, PhD
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
Adjunctive Diagnostic Instruments for PCI
08/01/2008
Larry S. Dean, MD, FACC, FAHA, FSCAI
Since the discovery of X-rays in 1895, there has been continuous development, first of imaging techniques, but over the last several decades, of therapeutics, to address the number-one killer of individuals in the industrialized world….heart...
Since the discovery of X-rays in 1895, there has been continuous development, first of imaging techniques, but over the last several decades, of therapeutics, to address the number-one killer of individuals in the industrialized world….heart...
Since the discovery of X-rays in...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Impact of Periprocedural Creatine Kinase-MB Isoenzyme Release
on Long-Term Mortality in Contemporary Percutaneous Coronary
Int
08/01/2008
Raphael A. Perry, MD, FRCP, BMBS, BSc; Anthony D. Grayson, BSc; Mohammed Andron, MSc, MBChB, MRCP, MD, MBBS; Rodney H. Stables, DM, MA, BM, BCh, FRCP, MD; Khaled Albouaini, MSc, MBChB, MRCP, MD, MBBS; Mohaned Egred, MBChB, MD, BSc(Hons), FRCP, BSc, MRCP; Elved B. Roberts, MB, MRCP, MD; Matthew A. Shaw, MSc, PhD, BSc; Albert E. Alahmar, MD, BSc, MBChB, MRCP; Nicholas D. Palmer, MB, MRCP, MD, BS, FRCP
Elevation of biochemical markers of myocardial damage following percutaneous coronary intervention (PCI) is frequently observed,1–4 however, its significance remains controversial.5,6 Multiple reports have demonstrated a linear relationship...
Elevation of biochemical markers of myocardial damage following percutaneous coronary intervention (PCI) is frequently observed,1–4 however, its significance remains controversial.5,6 Multiple reports have demonstrated a linear relationship...
Elevation of biochemical markers...
08/01/2008
Journal of Invasive Cardiology

News

HeartFlow Plaque Analysis
plaque analysis
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
09/22/2025
Heartflow also announced that Heartflow Plaque Analysis will be covered by Cigna across all of its lines of business, including Commercial and Medicare Advantage plans, beginning in October.
Heartflow also announced that Heartflow Plaque Analysis will be covered by Cigna across all of its lines of business, including Commercial and Medicare Advantage plans, beginning in October.
Heartflow also announced that...
09/22/2025
Cath Lab Digest
Cardiogenic Shock
New SCAI Initiative Targets Faster Shock Diagnosis and Care with ‘Door to Lactate Clearance’
09/19/2025
“SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis and Call to Action” was unveiled September 19 at the SCAI SHOCK Conference in Tampa, FL, with simultaneous publication in JSCAI.  
“SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis and Call to Action” was unveiled September 19 at the SCAI SHOCK Conference in Tampa, FL, with simultaneous publication in JSCAI.  
“SCAI Door to Lactate Clearance...
09/19/2025
Cath Lab Digest
Hyperkalemia
AccurKardia Announces Clinical Pilot Study of Its AK+ Guard ECG-based, AI-powered Hyperkalemia Detection Software
09/18/2025
Hyperkalemia, or an excess of serum potassium in the blood, is a common condition affecting patients with chronic kidney disease (CKD), end stage renal disease, and heart failure that can result in dangerous arrhythmias and sudden cardiac...
Hyperkalemia, or an excess of serum potassium in the blood, is a common condition affecting patients with chronic kidney disease (CKD), end stage renal disease, and heart failure that can result in dangerous arrhythmias and sudden cardiac...
Hyperkalemia, or an excess of...
09/18/2025
Cath Lab Digest
Patient Care
Hitting the Right Note: The Healing Power of Music Therapy in the Cardiac ICU
09/18/2025
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking...
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking...
Music therapy could...
09/18/2025
Cath Lab Digest
Pulmonary Embolism
Imperative Care Announces Late-Breaking Data Presentation and Peer-Reviewed Publication from Pivotal Trial of Symphony Thrombectomy System in Patients with Acute Pulmonary Embolism
09/18/2025
The Symphony Thrombectomy System is an aspiration catheter system engineered to deliver more efficient and effective clot removal in patients with venous thromboembolism (VTE). Symphony uniquely combines large-bore power with precise deep...
The Symphony Thrombectomy System is an aspiration catheter system engineered to deliver more efficient and effective clot removal in patients with venous thromboembolism (VTE). Symphony uniquely combines large-bore power with precise deep...
The Symphony Thrombectomy System...
09/18/2025
Cath Lab Digest
CVD
Cardiovascular Disease Risk Rises in Mexico, Despite Improved Cholesterol Control
09/18/2025
Despite improved statin use and cholesterol control, cardiovascular disease risk rose in Mexico between 2016 and 2023, according to a study being presented at ACC Latin America 2025 that used region-specific tools to more accurately predict...
Despite improved statin use and cholesterol control, cardiovascular disease risk rose in Mexico between 2016 and 2023, according to a study being presented at ACC Latin America 2025 that used region-specific tools to more accurately predict...
Despite improved statin use and...
09/18/2025
Cath Lab Digest
Thrombectomy
Penumbra's Lightning Bolt 6X with Trax Now Available in 150 cm, Bringing the Power of CAVT to More Distal Anatomy Below the Knee
09/16/2025
“Lightning Bolt 6X with TraX has been highly effective in addressing smaller embolized fragments in the AT,” says Dr. Visharad Patel at Wellstar North Fulton Hospital in Roswell, GA. “We have been impressed with its ability to navigate...
“Lightning Bolt 6X with TraX has been highly effective in addressing smaller embolized fragments in the AT,” says Dr. Visharad Patel at Wellstar North Fulton Hospital in Roswell, GA. “We have been impressed with its ability to navigate...
“Lightning Bolt 6X with TraX has...
09/16/2025
Cath Lab Digest
Heart Failure
ELEVATE-HFpEF: Medtronic Initiates Global Pivotal Study of Cardiac Pacing in New Patient Population
09/16/2025
Participants will either receive a pacemaker programmed with an elevated, personalized pacing rate, or one programmed to provide a non-personalized backup pacing rate if needed.
Participants will either receive a pacemaker programmed with an elevated, personalized pacing rate, or one programmed to provide a non-personalized backup pacing rate if needed.
Participants will either receive...
09/16/2025
Cath Lab Digest
Peripheral IVL
Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter Launched in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions
09/16/2025
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin...
09/16/2025
Cath Lab Digest
Dr. Annapoorna Kini (left) and her team outside of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab
AI Research
Mount Sinai Launches Cardiac Catheterization Artificial Intelligence Research Lab
09/16/2025
Annapoorna Kini, MD, will serve as Director of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab. The new lab will focus on many aspects of interventional cardiology, from procedural to educational.
Annapoorna Kini, MD, will serve as Director of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab. The new lab will focus on many aspects of interventional cardiology, from procedural to educational.
Annapoorna Kini, MD, will serve...
09/16/2025
Cath Lab Digest

Sovari Figure 1
Clinical Videos
Leadless Pacemaker Placement Through the Subclavian Vein: An Alternative to the Femoral Route
09/26/2025
Video Supplement to "Leadless Pacemaker Placement Through the Subclavian Vein: An Alternative to the Femoral Route" (Clinical Image).
Video Supplement to "Leadless Pacemaker Placement Through the Subclavian Vein: An Alternative to the Femoral Route" (Clinical Image).
Video Supplement to "Leadless...
09/26/2025
Journal of Invasive Cardiology
Clinical Images
Leadless Pacemaker Placement Through the Subclavian Vein: An Alternative to the Femoral Route
09/26/2025
09/26/2025
Journal of Invasive Cardiology
Brief Communication
Aortic Valve Calcification Alone Identifies Transcatheter Aortic Valve Replacement Benefit in Classical Low-Flow, Low-Gradient Aortic Stenosis
09/25/2025
The authors sought to determine if the prognostic relevance of aortic valve calcification differs by low-flow, low-gradient aortic stenosis subtype.
The authors sought to determine if the prognostic relevance of aortic valve calcification differs by low-flow, low-gradient aortic stenosis subtype.
The authors sought to determine...
09/25/2025
Journal of Invasive Cardiology
Offiah Figure
Clinical Videos
A Kissing WATCHMAN Approach to Bilobar Left Atrial Appendage Occlusion
09/24/2025
Video Supplement to "A Kissing WATCHMAN Approach to Bilobar Left Atrial Appendage Occlusion" (Clinical Image).
Video Supplement to "A Kissing WATCHMAN Approach to Bilobar Left Atrial Appendage Occlusion" (Clinical Image).
Video Supplement to "A Kissing...
09/24/2025
Journal of Invasive Cardiology
Clinical Images
A Kissing WATCHMAN Approach to Bilobar Left Atrial Appendage Occlusion
09/24/2025
An 83-year-old man with a history of atrial fibrillation presented with a subdural hematoma. His apixaban was stopped and a pacemaker was implanted.
An 83-year-old man with a history of atrial fibrillation presented with a subdural hematoma. His apixaban was stopped and a pacemaker was implanted.
An 83-year-old man with a...
09/24/2025
Journal of Invasive Cardiology
Casazza headshot
Author Interview
Ocular Radiation Exposure of the Primary Operator Performing Selective Coronary Angiography From a Radial Artery Approach
09/23/2025
Richard Casazza, MAS
Dr Richard Casazza shares background and insights on his article, "Ocular Radiation Exposure of the Primary Operator Performing Selective Coronary Angiography From a Radial Artery Approach."
Dr Richard Casazza shares background and insights on his article, "Ocular Radiation Exposure of the Primary Operator Performing Selective Coronary Angiography From a Radial Artery Approach."
Dr Richard Casazza shares...
09/23/2025
Journal of Invasive Cardiology
HeartFlow Plaque Analysis
plaque analysis
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
09/22/2025
Heartflow also announced that Heartflow Plaque Analysis will be covered by Cigna across all of its lines of business, including Commercial and Medicare Advantage plans, beginning in October.
Heartflow also announced that Heartflow Plaque Analysis will be covered by Cigna across all of its lines of business, including Commercial and Medicare Advantage plans, beginning in October.
Heartflow also announced that...
09/22/2025
Cath Lab Digest
Cardiogenic Shock
New SCAI Initiative Targets Faster Shock Diagnosis and Care with ‘Door to Lactate Clearance’
09/19/2025
“SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis and Call to Action” was unveiled September 19 at the SCAI SHOCK Conference in Tampa, FL, with simultaneous publication in JSCAI.  
“SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis and Call to Action” was unveiled September 19 at the SCAI SHOCK Conference in Tampa, FL, with simultaneous publication in JSCAI.  
“SCAI Door to Lactate Clearance...
09/19/2025
Cath Lab Digest
Hyperkalemia
AccurKardia Announces Clinical Pilot Study of Its AK+ Guard ECG-based, AI-powered Hyperkalemia Detection Software
09/18/2025
Hyperkalemia, or an excess of serum potassium in the blood, is a common condition affecting patients with chronic kidney disease (CKD), end stage renal disease, and heart failure that can result in dangerous arrhythmias and sudden cardiac...
Hyperkalemia, or an excess of serum potassium in the blood, is a common condition affecting patients with chronic kidney disease (CKD), end stage renal disease, and heart failure that can result in dangerous arrhythmias and sudden cardiac...
Hyperkalemia, or an excess of...
09/18/2025
Cath Lab Digest
Patient Care
Hitting the Right Note: The Healing Power of Music Therapy in the Cardiac ICU
09/18/2025
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking...
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking...
Music therapy could...
09/18/2025
Cath Lab Digest

March 2008 Volume 20 Issue 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use